Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-047185

Chief Medical Officer gave up 2,834 shares (to pay taxes)

  • Chief Medical Officer acquired 5,643 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2019-08-20 Option exercise +5,643 52,518 D
Ho Carole Chief Medical Officer 2019-08-21 Shares withheld for taxes −2,834 $18.59 $52,671 49,684 D
Derivatives
Ho Carole Chief Medical Officer 2019-08-20 Option exercise · Restricted Stock Unites −5,643 5,643 D
Loading xslF345X03/doc4.xml…